Related Research Articles
Ricin ( RY-sin) is a lectin (a carbohydrate-binding protein) and a highly potent toxin produced in the seeds of the castor oil plant, Ricinus communis. The median lethal dose (LD50) of ricin for mice is around 22 micrograms per kilogram of body weight via intraperitoneal injection. Oral exposure to ricin is far less toxic. An estimated lethal oral dose in humans is approximately 1 milligram per kilogram of body weight.
Ellen S. Vitetta is the director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.
The Cockrell School of Engineering is one of the eighteen colleges within the University of Texas at Austin. It has more than 8,000 students enrolled in eleven undergraduate and thirteen graduate programs. The college is ranked 10th in the world according to the Academic Ranking of World Universities, 9th nationally for undergraduate programs and 6th nationally for graduate programs by U.S. News & World Report. Nine of the ten undergraduate programs and seven of the eleven graduate programs are ranked in the top ten nationally. Annual research expenditures are over $180 million and the school has the fourth-largest number of faculty in the National Academy of Engineering.
Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former Director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.
Human betaherpesvirus 5, also called human cytomegalovirus (HCMV), is species of virus in the genus Cytomegalovirus, which in turn is a member of the viral family known as Herpesviridae or herpesviruses. It is also commonly called CMV. Within Herpesviridae, HCMV belongs to the Betaherpesvirinae subfamily, which also includes cytomegaloviruses from other mammals. CMV is a double-stranded DNA virus.
Bavituximab (PGN401) is a human-mouse chimeric monoclonal antibody against phosphatidylserine, which is a component of cell membranes that is exposed when a cell is transformed into solid tumor cancer cell or dies, and when cells are infected with hepatitis C. The process of cell death is highly controlled and so there usually no immune response to phosphatidylserine but when bavituximab binds to it, the conjugate appears to stimulate an immune response in humans.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
Blueberry muffin baby, also known as extramedullary hematopoiesis, describes a newborn baby with multiple purpura, associated with several non-cancerous and cancerous conditions in which extra blood is produced in the skin. The bumps range from 1 to 7 mm, do not blanche and have a tendency to occur on the head, neck and trunk. They often fade by three to six weeks after birth, leaving brownish marks. When due to a cancer, the bumps tend to be fewer, firmer and larger.
Gene therapy utilizes the delivery of DNA into cells, which can be accomplished by several methods, summarized below. The two major classes of methods are those that use recombinant viruses and those that use naked DNA or DNA complexes.
MHC multimers are oligomeric forms of MHC molecules, designed to identify and isolate T-cells with high affinity to specific antigens amid a large group of unrelated T-cells. Multimers generally range in size from dimers to octamers; however, some companies use even higher quantities of MHC per multimer. Multimers may be used to display class 1 MHC, class 2 MHC, or nonclassical molecules from species such as monkeys, mice, and humans.
Jennifer Anne Doudna is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side.
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has 4 drugs in pivotal studies: tominersen for Huntington’s disease, tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
Jennifer L. West is an American bioengineer. She is the current Dean of Engineering and Applied Science at the University of Virginia. She was the Fitzpatrick University Professor of Biomedical Engineering at Duke University from 2012-2021. In 2000, West cofounded Nanospectra Biosciences in Houston to develop a cancer therapy based on gold nanoparticles that destroy tumor cells and has been listed by MIT Technology Review as one of the 100 most innovative young scientists and engineers world wide.
Christine E. Schmidt is an American biomedical engineer. As a professor at the University of Florida, Schmidt was inducted into the Florida Inventors Hall of Fame for her creation of the Avance Nerve Graft which has "improved the lives of numerous patients suffering from peripheral nerve damage."
Elizabeth Cosgriff-Hernandez is an American biomedical engineer who is a professor at the University of Texas at Austin. Her work involves the development of polymeric biomaterials for medical devices and tissue regeneration. She also serves on the scientific advisory board of ECM Biosurgery and as a consultant to several companies on biostability evaluation of medical devices. Cosgriff-Hernandez is an associate editor of the Journal of Materials Chemistry B and Fellow of the International Union of Societies for Biomaterials Science and Engineering, Biomedical Engineering Society, Royal Society of Chemistry, and the American Institute for Medical and Biological Engineering.
Elizabeth Sally Ward is a British physician who is Director of Translational Immunology at the Centre for Cancer Immunology in the University of Southampton. She was elected Fellow of the Royal Society in 2022.
Songi Han is an American chemist who is a professor in the Department of Chemistry and Biochemistry at the University of California, Santa Barbara. Her research considers electron and nuclear spins as sensors and detectors. She was elected a Fellow of the International Society of Magnetic Resonance in 2019 and President of the International EPR Society in 2020.
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.
References
- ↑ "Maynard, Jennifer - Interdisciplinary Life Sciences Graduate Programs - CNS Directory". cns.utexas.edu. Retrieved 2023-02-25.
- ↑ "Engineering antibody therapeutics : approaches to neutralizing bacterial toxins | WorldCat.org". www.worldcat.org. Retrieved 2023-02-25.
- ↑ "Jennifer Maynard, Ph.D." Janux Therapeutics. Retrieved 2023-02-25.
- ↑ "Jennifer Maynard". www.che.utexas.edu. Retrieved 2023-02-25.
- ↑ "Outfitting T cell receptors to combat a widespread and sometimes deadly virus". EurekAlert!. Retrieved 2023-02-25.
- ↑ "» Anthrax Treatment Engineered by Texas ChE Researchers Gains FDA Approval". utw10279.utweb.utexas.edu. Retrieved 2023-02-25.
- ↑ "Releviate Therapeutics Appoints Jennifer Maynard to Its Scientific Advisory Board". www.businesswire.com. 2021-05-04. Retrieved 2023-02-25.
- ↑ "Maynard, Jennifer". The David and Lucile Packard Foundation. Retrieved 2023-02-25.
- ↑ Leahy, Cory (2012-02-13). "Teaching excellence". UT News. Retrieved 2023-02-25.
- ↑ "» Inventor of the Year Award". utw10279.utweb.utexas.edu. Retrieved 2023-02-25.
- ↑ "Jennifer A. Maynard, Ph.D. COF-2157 - AIMBE" . Retrieved 2023-02-25.
- ↑ Rittenhouse, Rebekah (2023-02-14). "NAI Welcomes 95 New Emerging Innovators". NAI. Retrieved 2023-02-25.
- ↑ Burkhart, Ross (2023-02-14). "4 Professors Among National Academy of Inventors' Top Members". UT News. Retrieved 2023-02-25.
| General | |
|---|---|
| Scientific databases | |
